Jilin Aodong disclosed its earnings forecast, expecting attributable net profit for the first half of 2026 to be between 1.922 billion and 2.179 billion yuan, a year-on-year increase of 50% to 70%. Deducted non-recurring net profit is expected to be between 2.088 billion and 2.345 billion yuan, up 78.94% to 100.9% year-on-year. Basic earnings per share are projected at 1.64 yuan to 1.86 yuan. The company said the sharp rise in performance is mainly due to a year-on-year increase in investment income.
Jilin Aodong Pharmaceutical Group Co LtdCompany expects net profit to rise 50-70% YoY due to higher investment income.